Consistent clinical cure rates in cSSTI across infection types and in patients with comorbidities1-5,*
ZINFORO® demonstrated microbiological response and clinical cure rates at TOC (CANVAS 1 and CANVAS 2 integrated analysis).1
Clinical cure rates by analysis population at the TOC visit1
ZINFORO®: 92.7% of patients (n=434/468)
Vancomycin + Aztreonam: 94.4% of patients (n=421/446)
Clinical cure rates (CE population) at the TOC visit1:
ZINFORO®: 91.6% of patients (n=559/610)
Vancomycin + Aztreonam: 92.7% of patients (n=549/592)
CANVAS 1 and CANVAS 2 integrated analysis1
Header | ||
---|---|---|
Header | Header | Header |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Adapted from Corey G, et al. 2010.
*There is no experience with ZINFORO® in the treatment of cSSTI in the following patient groups6: The immunocompromised, patients with severe sepsis/septic shock, necrotising fasciitis, perirectal abscess and patients with third-degree and extensive burns. There is limited experience in treating patients with diabetic foot infections. Caution is advised when treating such patients.
†Bacteraemia was present in 4% of the patients when baseline medical characteristics were assessed.1
CANVAS, CeftAroliNe fosamil versus VAncomycin in Skin and skin structure infection; CE, clinically evaluable; cSSTI, complicated skin and soft tissue infection; ME, microbiologically evaluable; TOC, test of cure.
References:
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered Medical Practitioner*, please visit
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.